Novel conditioning regimen in upfront autologous stem cell transplantation in high-risk DLBCL

被引：0
|
作者：
Jiexian Ma
Shunrong Sun
Yingwei Hu
Min Wu
Lin Shen
Wulipan Fulati
Zilan Huang
Wensi Qian
Pingping Chen
Mingyue Chen
Yanhui Xie
机构：
[1] Huadong Hospital Affiliated with Fudan University,Department of Hematology
来源：
Bone Marrow Transplantation | 2022年 / 57卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1612 / 1614
页数：2
相关论文
共 50 条
  • [1] Novel conditioning regimen in upfront autologous stem cell transplantation in high-risk DLBCL
    Ma, Jiexian
    Sun, Shunrong
    Hu, Yingwei
    Wu, Min
    Shen, Lin
    Fulati, Wulipan
    Huang, Zilan
    Qian, Wensi
    Chen, Pingping
    Chen, Mingyue
    Xie, Yanhui
    BONE MARROW TRANSPLANTATION, 2022, 57 (10) : 1612 - 1614
  • [2] Bortezomib and BEAM conditioning regimen for upfront autologous stem cell transplantation in mantle cell lymphoma
    Huynh, A.
    Roussel, M.
    Ysebaert, L.
    Recher, C.
    Huguet, F.
    Nouvel, C.
    Laurent, G.
    Attal, M.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S242 - S242
  • [3] MCVAC regimen in autologous peripheral blood stem cell transplantation for high-risk diffuse large B cell lymphoma (DLBCL)
    Kato, J
    Yokoyama, K
    Mori, T
    Tsukada, Y
    Chen, CK
    Ikeda, Y
    Okamoto, SI
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 117 - 118
  • [4] Autologous stem cell transplantation for high-risk Hodgkin's disease:: improvement over time and impact of conditioning regimen
    Subirà, M
    Sureda, A
    Martino, R
    García, J
    Altés, A
    Canals, C
    Domingo-Albós, A
    Brunet, S
    Sierra, J
    HAEMATOLOGICA, 2000, 85 (02) : 167 - 172
  • [5] MCVAC as an effective non-TBI conditioning regimen for autologous stem cell transplantation in patients with high-risk lymphoma
    Watanabe, R
    Okamoto, S
    Mori, T
    Asahi, A
    Ikeda, Y
    BONE MARROW TRANSPLANTATION, 2001, 27 : S266 - S267
  • [6] THE ROLE OF UPFRONT AUTOLOGOUS STEM CELL TRANSPLANTATION FOR HIGH-RISK PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
    Cho, H.
    Kim, S. J.
    Park, H.
    Lee, J. Y.
    Jang, J. E.
    Kim, Y.
    Cheong, J. W.
    Min, Y. H.
    Kim, J. S.
    HAEMATOLOGICA, 2015, 100 : 401 - 402
  • [7] A novel reduced intensity conditioning regimen for patients with high-risk hematological malignancies undergoing allogeneic stem cell transplantation
    G S Hobbs
    N Kaur
    P Hilden
    D Ponce
    C Cho
    H R Castro-Malaspina
    S Giralt
    J D Goldberg
    A A Jakubowski
    E B Papadopoulos
    C Sauter
    G Koehne
    J Yahalom
    S Delvin
    J N Barker
    M-A Perales
    Bone Marrow Transplantation, 2016, 51 : 1010 - 1012
  • [8] A novel reduced intensity conditioning regimen for patients with high-risk hematological malignancies undergoing allogeneic stem cell transplantation
    Hobbs, G. S.
    Kaur, N.
    Hilden, P.
    Ponce, D.
    Cho, C.
    Castro-Malaspina, H. R.
    Giralt, S.
    Goldberg, J. D.
    Jakubowski, A. A.
    Papadopoulos, E. B.
    Sauter, C.
    Koehne, G.
    Yahalom, J.
    Delvin, S.
    Barker, J. N.
    Perales, M-A
    BONE MARROW TRANSPLANTATION, 2016, 51 (07) : 1010 - 1012
  • [9] High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk Hodgkin's lymphoma
    Di Ianni, Mauro
    Ballanti, Stelvio
    Iodice, Giuseppe
    Reale, Antonia
    Falzetti, Franca
    Minelli, Olivia
    Serio, Gabriella
    Martelli, Massimo F.
    Dammacco, Franco
    Vacca, Angelo
    Ria, Roberto
    HEMATOLOGY, 2012, 17 (01) : 23 - 27
  • [10] BTM: an alternative conditioning regimen for autologous stem cell transplantation
    De Rosa, G.
    Morelli, E.
    Montante, B.
    De Rosa, A.
    Rotoli, B.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S252 - S252
12345